Clinical Trial Update: Carfilzomib, Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in High- Risk SMM [Phase 2]

View source ↗

Summary

Phase 2 trial comparing carfilzomib, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone in high-risk smouldering multiple myeloma is active/n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smouldering Multiple Myeloma

Drugs mentioned

• Carfilzomib (carfilzomib)
• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland | Conditions: Smouldering Myeloma | Phase 2 | Status: ACTIVE_NOT_RECRUITING